CD3E and neoplasm: The majority of cPARP1-positive cells were non-tumor cells (e.g., CD3E+, CD11C+, or CD31+), particularly in peritumoral regions, consistent with the short half-lives of activated T cells, neutrophils and other immune cells (Fig. 5b, c).